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Herpes Simplex Virus 1 Glycoprotein M and the MembraneAssociated Protein UL11 Are Required for Virus-Induced Cell Fusion
and Efficient Virus Entry
In-Joong Kim, Vladimir N. Chouljenko, Jason D. Walker, Konstantin G. Kousoulas
Division of Biotechnology and Molecular Medicine, Department of Pathobiological Sciences, School of Veterinary Medicine, Louisiana State University, Baton Rouge,
Louisiana, USA

H

erpes simplex virus 1 (HSV-1) encodes at least 11 glycoproteins as well as several membrane-associated proteins which
play important roles in viral entry and virus-induced cell fusion.
Virus-induced cell fusion is apparent in herpetic lesions and is
thought to facilitate virion transmission to adjacent cells without
exposure to the host humoral immune system, particularly neutralizing antibody (reviewed in reference 1). Certain mutations in
the UL20 gene (2–4), the UL24 gene (5, 6), the UL27 gene encoding glycoprotein B (gB) (7, 8), and the UL53 gene coding for gK
(9–14) drastically enhance virus-induced cell fusion (syncytial or
syn mutations). Recently, it has been suggested that gB is the sole
fusogenic glycoprotein while glycoproteins gD and gH/gL are required to activate gB’s fusogenicity in conjunction with specific
cellular receptors (15). In this membrane fusion model, binding of
gD to its cognate receptors, including nectin-1, herpesvirus entry
mediator (HVEM), and other receptors (16–22), is thought to
trigger sequential conformational changes in gH/gL and gB, causing fusion of the viral envelope with cellular membranes during
virus entry as well as fusion among cellular membranes (23, 24).
Extensive membrane fusion can be induced by coexpressing glycoproteins gB, gD, and gH/gL in cell lines (25, 26), suggesting that
these glycoproteins are sufficient for membrane fusion. However,
virus-induced cell fusion is regulated by a number of other viral
proteins, since wild-type viruses cause a limited amount of fusion
(27) and a lack of either glycoprotein gK or the membrane protein
UL20 severely inhibits membrane fusion (4, 28).
We have shown that HSV-1 gK and UL20 functionally and
physically interact and that these interactions are absolutely necessary for their coordinate intracellular transport, cell surface expression, and membrane fusion functions in the HSV-1 life cycle
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(28, 29). Furthermore, we have shown that a peptide comprised of
the amino-terminal 82 amino acids of gK (gKa) expressed in trans
complemented gB-mediated cell fusion and may physically interact with gB and gH in infected cells (30). These results suggest that
gB-mediated virus-induced cell fusion is regulated via direct interactions with gK and UL20 (30, 31).
Glycoprotein gM is a conserved type III integral membrane
protein with multiple transmembrane domains that forms a complex with pUL49.5 (gN) (reviewed in reference 1). Deletion of the
gM gene does not abrogate HSV-1 replication but inhibits the
ability of the virus to spread (32). gM expression causes relocalization of several membrane proteins from the cell surface to the
trans-Golgi network (TGN) (33, 34). Thus, gM may function to
retain viral glycoproteins at the TGN or retrieve them from the
plasma membrane to the TGN (32). Expression of HSV-1, pseudorabies virus (PRV), and Kaposi’s sarcoma-associated herpesvirus (KSHV, or human herpesvirus 8 [HHV-8]) gM and gN in
transfected cells inhibited cell fusion caused by simultaneous expression of glycoproteins gB, gD, gH, and gL, suggesting that
gM/gN may modulate membrane fusion (34, 35). Also, lack of gM
was reported to inhibit virus-induced cell fusion caused by a single
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Herpes simplex virus 1 (HSV-1) facilitates virus entry into cells and cell-to-cell spread by mediating fusion of the viral envelope
with cellular membranes and fusion of adjacent cellular membranes. Although virus strains isolated from herpetic lesions cause
limited cell fusion in cell culture, clinical herpetic lesions typically contain large syncytia, underscoring the importance of cellto-cell fusion in virus spread in infected tissues. Certain mutations in glycoprotein B (gB), gK, UL20, and other viral genes drastically enhance virus-induced cell fusion in vitro and in vivo. Recent work has suggested that gB is the sole fusogenic glycoprotein,
regulated by interactions with the viral glycoproteins gD, gH/gL, and gK, membrane protein UL20, and cellular receptors. Recombinant viruses were constructed to abolish either gM or UL11 expression in the presence of strong syncytial mutations in
either gB or gK. Virus-induced cell fusion caused by deletion of the carboxyl-terminal 28 amino acids of gB or the dominant syncytial mutation in gK (Ala to Val at amino acid 40) was drastically reduced in the absence of gM. Similarly, syncytial mutations in
either gB or gK did not cause cell fusion in the absence of UL11. Neither the gM nor UL11 gene deletion substantially affected gB,
gC, gD, gE, and gH glycoprotein synthesis and expression on infected cell surfaces. Two-way immunoprecipitation experiments
revealed that the membrane protein UL20, which is found as a protein complex with gK, interacted with gM while gM did not
interact with other viral glycoproteins. Viruses produced in the absence of gM or UL11 entered into cells more slowly than their
parental wild-type virus strain. Collectively, these results indicate that gM and UL11 are required for efficient membrane fusion
events during virus entry and virus spread.
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amino acid substitution in the carboxyl terminus of gB (A855V;
gBsyn) (36, 37).
UL11 is a 96-amino-acid myristoylated and palmitoylated tegument protein anchored into the cytoplasmic side of cell membranes (32, 38). UL11 has been suggested to play a role in recruiting viral proteins to the virion assembly site at the TGN (32). UL11
is known to interact with UL16 and gE through its N-terminal
(39–41) and C-terminal (42) domains, respectively. Although
absence of UL11 in HSV and PRV revealed only moderate defects
in viral replication, the human cytomegalovirus (HCMV, or
HHV-5) UL11 homologue is essential for virus replication (32).
HSV-1 UL11 was recently shown to form a protein complex with
gE, UL16, and UL21 that may be required for efficient virus spread
(43).
Recently, we utilized mutant viruses lacking one or more viral
genes to show that the deletion of either the gK or UL20 gene
produced significantly greater defects in virion envelopment and
overall virus replication than deletion of the carboxyl terminus of
either gD, UL11, gM, or gE alone or in various combinations (44).
Herein, we investigated whether the lack of either gM or UL11
affected the ability of dominant syncytial mutations in either gB or
gK to cause extensive virus-induced cell fusion. We found that
both gM and UL11 are required for virus-induced cell fusion.
Moreover, mutant viruses lacking either gM or UL11 exhibited
slower kinetics of entry into Vero cells than the parental virus,
suggesting that gM and UL11 are involved in membrane fusion
phenomena during both virus-induced cell fusion and virus entry.
MATERIALS AND METHODS
Cells, antibodies, and plasmids. African green monkey kidney (Vero)
cells were obtained from the American Type Culture Collection (Rockville, MD). Cells were maintained in Dulbecco’s modified Eagle’s medium
(DMEM; Life Technologies-Gibco, Carlsbad, CA), supplemented with
10% fetal calf serum (FCS; Life Technologies-Gibco, Carlsbad, CA) and
Primocin antibiotic (InvivoGen, San Diego, CA). Antibodies used include
anti-HSV-1 gB, gC, gD, gE, and ICP5 (VP5) monoclonal antibodies
(MAbs) (Virusys, Sykesville, MD), Alexa Fluor 488-conjugated goat antimouse IgG (Life Technologies-Molecular Probes, Carlsbad, CA), antiHSV-1 gH MAb (Abcam, Cambridge, MA), anti-FLAG MAb (Sigma, St.
Louis, MO), rabbit anti-HSV-1 gM polyclonal antibody (pAb) (a gift from
Joel Baines, Cornell University, Ithaca, NY), and rabbit anti-HSV-1 UL11
pAb (a gift from John Wills, Pennsylvania State University, Hershey, PA).
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For transient-complementation experiments, HSV-1(F) UL10 (gM) and
UL11 genes were cloned into pCDNA3.1 plasmid (Life TechnologiesInvitrogen, Carlsbad, CA) and named pCgM and pCUL11, respectively.
Construction of HSV-1 mutant viruses. Mutagenesis was accomplished in Escherichia coli using the markerless two-step Red recombination mutagenesis system using synthetic oligonucleotides (45, 46), implemented on the bacterial artificial chromosome (BAC) plasmid pYEbac102
carrying the HSV-1(F) genome (47) (a kind gift from Y. Kawaguchi, University of Tokyo, Tokyo, Japan). Construction of the HSV-1 mutants
⌬gM2 (⌬gM) and ⌬UL11 was described previously (44). Briefly, the ⌬gM
recombinant virus was constructed by altering two potential initiation
codon sites (from ATG to CTG and from ATG to ATT, respectively)
located 57 bp apart at the beginning of the UL10 open reading frame
(ORF) (48) (Fig. 1). The ⌬UL11 virus was constructed by changing the
initiation codon from ATG to CTG. The gB⌬28 recombinant virus was
produced by introducing a stop codon causing truncation of gB by 28
amino acids. The gKsyn20 recombinant virus was constructed by introducing a point mutation (Ala to Val) at gK amino acid position 40. The
⌬gM and ⌬UL11 mutant viruses were used as the backbone for construction of the double mutants gB⌬28/⌬gM, gKsyn20/⌬gM, gB⌬28/⌬UL11,
and gKsyn20/⌬UL11 by introducing the designated mutations (Fig. 1).
Confirmation of the targeted mutations and recovery of infectious
viruses. HSV-1 BAC DNAs were purified from 50 ml of overnight BAC
cultures with the Qiagen large-construct kit (Qiagen, Valencia, CA). Using PCR test primers designed to lie outside the target mutation site(s), all
mutated DNA regions were sequenced to verify the presence of the desired
mutations in BACs. Viruses were recovered from cells transfected with
BAC plasmids as we have described previously (45), and mutations were
confirmed by DNA sequencing. To further validate the recombinant viruses, the entire genomes of recovered viruses from BACs were sequenced
via Ion Torrent next-generation sequencing (Life Technologies-Invitrogen, Carlsbad, CA). Briefly, total genomic DNA (gDNA) was extracted
from the virus-infected Vero cells using the PureLink genomic DNA
minikit (Life Technologies-Invitrogen, Carlsbad, CA). High-quality fragment libraries of each virus were prepared from the extracted total gDNAs
using the Ion Xpress Plus fragment library kit (Life Technologies-Invitrogen, Carlsbad, CA). The fragment libraries were subsequently applied to
Ion 316 chips and were analyzed on the Ion Personal Genome Machine
system (Life Technologies-Invitrogen, Carlsbad, CA).
Plaque morphology of mutant viruses on Vero and transiently complementing cells. Visual analysis of plaque morphology of mutant viruses
was performed as we have previously described (28, 45, 49, 50). Confluent
monolayers of Vero cells were transfected with 1 g of gM- or UL11expressing plasmid (one well of a 12-well tissue culture plate) using Lipo-
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FIG 1 Schematic representation of mutant viruses. (A) Prototypic arrangement of the HSV-1(F)-YE102 genome with the unique long (UL) and unique short
(US) regions flanked by the terminal repeat (TR) and internal repeat (IR) regions. (B) Relative genomic positions and gene arrangements of targeted genes
encoding the viral glycoproteins gB (UL27), gM (UL10), and gK (UL53) and membrane protein UL11. (C) Schematic representation of engineered mutations.
Mutant viruses containing the ⌬gM and ⌬UL11 mutations were produced by changing the initiation codons of each gene (hatched regions). Mutant viruses
containing gB⌬28 were produced by introduction of a stop codon causing truncation of gB by 28 amino acids (hatched region in gB). Mutant viruses containing
gKsyn20 were produced by a point mutation (Ala to Val) at gK amino acid position 40 (white vertical line in gK).

HSV-1 gM and UL11 Are Required for Membrane Fusion
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Two-way immunoprecipitation experiments. Immunoprecipitation
of proteins was essentially as described previously (52). Vero cell monolayers were infected with HSV-1(F) or HSV-1(F)-YE102-VC1 (having
UL20 protein tagged with the 3⫻FLAG epitope and gK tagged with the V5
epitope) (52). Cellular extracts were prepared at 24 hpi, and the designated proteins were precipitated by protein G magnetic Dynabeads (Life
Technologies-Novex, Carlsbad, CA) bound to the corresponding antibodies according to the manufacturer’s instructions. The presence of gB,
gM, and UL20 was visualized by Western immunoblots using anti-gB,
anti-gM, and anti-Flag (UL20) antibodies before or after immunoprecipitation with the same set of antibodies.
Virus penetration kinetics assay. The kinetics of virus penetration
was measured as described previously (29, 52). Briefly, subconfluent
monolayers of Vero cells in 12-well tissue culture plates were infected at
4°C for 1 h with approximately 250 PFU of wild-type HSV-1(F), ⌬gM
mutant, and ⌬UL11 mutant viruses. Subsequently, infected cell cultures
were incubated at 34°C to allow virus penetration. Immediately thereafter
(0 min) and at 30, 60, 120, and 180 min, the virus inoculum was removed
and washed once with PBS (pH 7.4), and then the remaining extracellular
virus was inactivated by treatment with low-pH PBS (pH 3.0). The cells
were washed once with PBS and DMEM without serum sequentially and
then overlaid with 1% methylcellulose in DMEM supplemented with 2%
FCS. The cells were fixed with ice-cold methanol at 48 hpi, and virus
plaques were counted after immunohistochemical staining (30). Mean
values and standard deviations of three independent experiments were
calculated. To determine the entry kinetics, linear regression slopes during the exponential growth period, from 0 to 120 min, were calculated.

RESULTS

Construction of recombinant viruses. Deletion of the carboxylterminal 28 amino acids of gB (⌬28) or an Ala-to-Val mutation
(syn20) in the amino terminus of gK causes extensive virusinduced cell fusion (9, 51, 53). To investigate the role of gM and
UL11 in virus-induced cell fusion, we constructed a set of mutant viruses containing these syncytial mutations in the presence or absence of mutations that prevented expression of either the gM or UL11 gene using the HSV-1(F) genome cloned
as a BAC (see Materials and Methods). The set of mutant viruses that were constructed included the following: (i) gB⌬28,
(ii) gB⌬28/⌬gM, (iii) gB⌬28/⌬UL11, (iv) gKsyn20, (v)
gKsyn20/⌬gM, and (vi) gKsyn20/⌬UL11 (Fig. 1 and 2).
Validation of recombinant viruses. Individual mutant viruses were recovered by transfecting DNA of each constructed
mutant BAC into Vero cells, and the entire genomes of the
parental HSV-1(F) virus and all mutant viruses were sequenced
(see Materials and Methods). Viral genomes matched very well
to the published HSV-1(F) genomic sequence (GenBank accession number GU734771.1), with the exception of 37 nucleotide
changes resulting in 13 amino acid changes between the published HSV-1(F) and our HSV-1(F) strain, which is derived
from pYE102bac (Table 1). Comparison of the HSV-1(F)pYE102bac with each mutant virus revealed the presence of
each engineered mutation, while no other nucleotide changes
were observed.
Characterization of mutant viruses. The plaque morphology
of each recombinant virus was characterized as described in Materials and Methods. As expected, the recombinant viruses gB⌬28
and gKsyn20 caused extensive cell fusion (Fig. 2A). In contrast,
lack of either gM or UL11 expression in the presence of either a
gB⌬28 or gKsyn20 mutation caused significantly reduced levels of
cell-to-cell fusion and decreased plaque sizes (Fig. 2B). To test
whether these plaque changes were due primarily to lack of either
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fectamine 2000 transfection reagent (Life Technologies-Invitrogen, Carlsbad, CA). At 24 h posttransfection, cells were infected at a multiplicity of
infection (MOI) of 0.0001, with each mutant virus lacking gM or UL11. At
48 h postinfection (hpi), the infected cells were fixed with ice-cold methanol. Plaques were visualized after immunohistochemical staining with
polyclonal anti-HSV rabbit sera as described earlier (30). More than 50
independent viral plaques were examined to assess relative levels of syncytium formation and select individual plaques as representative plaques
for each experiment.
One-step viral growth kinetics. Analysis of one-step growth kinetics
was performed as we have described previously (29, 51). Briefly, nearly
confluent Vero cell monolayers in 12-well plates were infected with each
virus in triplicate at either a low MOI (0.2) or high MOI (3.0) for 1 h at
4°C. Thereafter, plates were incubated at 37°C and 5% CO2, and virus was
allowed to penetrate for 1 h at 37°C. Any remaining extracellular virus was
inactivated by low-pH treatment (pH 3.0) for 10 to 15 s, and the plates
were incubated at 37°C and 5% CO2. At 12 and 24 hpi, virus stocks were
prepared and viral titers were calculated by endpoint titration on Vero
cells. Viral plaques were counted after immunohistochemical staining
with rabbit anti-HSV-1 pAb as previously described (30).
SDS-PAGE and Western immunoblot assay. Western immunoblot
analysis was carried out essentially as described earlier (30). Briefly, confluent Vero cell monolayers were infected with the indicated virus at an
MOI of 3. At 24 hpi, cells were collected by low-speed centrifugation,
washed twice with ice-cold phosphate-buffered saline (PBS), and lysed
with NP-40 lysis buffer (Life Technologies-Novex, Carlsbad, CA). The
collected samples were mixed with SDS-PAGE sample buffer (Bio-Rad,
Hercules, CA) at a 1:1 ratio and were electrophoretically separated by
sodium dodecyl sulfate-polyacrylamide gel electrophoresis (Tris-HEPESSDS gradient 4 to 20% gels; Thermo Scientific, Waltham, MA). Following
electrophoresis, four identical gels were transferred to a nitrocellulose
membrane under a constant current. Membranes were blocked in Trisbuffered saline containing 0.1% Tween 20 (TBST) plus 5% nonfat milk
for 1 h at room temperature and were probed with primary MAbs overnight at 4°C. Goat anti-mouse secondary antibody conjugated with horseradish peroxidase (HRP) and enhanced chemiluminescence (ECL)
(GE Healthcare, Little Chalfont, United Kingdom) substrate were used for
detection purposes.
Quantification of cell-to-cell fusion. A luciferase-based cell-to-cell
fusion assay was performed essentially as described earlier (30). Briefly, a
subconfluent monolayer of Vero cells in a 6-well plate was transfected
with 2 g of plasmid containing either the T7 polymerase gene under the
cytomegalovirus (CMV) promoter (effector cells) or the T7-dependent
luciferase gene (target cells) by using Lipofectamine 2000 transfection
reagent. As positive and negative controls, cells were transfected with both
of the plasmids simultaneously and with pCAGGS empty vector plasmid,
respectively. Twelve hours after each transfection, the two different cell
populations, effector and target cells or negative cells and target cells, were
detached and reseeded to a new 12-well plate at a 1:1 ratio for experimental groups and negative-control groups, respectively. At 24 h posttransfection, cells were infected with wild-type and mutant viruses at an MOI of
0.2. At 12 and 24 hpi, cells were washed twice with ice-cold PBS and lysed
with passive lysis buffer (Promega, Madison, WI). The lysates were clarified by centrifugation at 10,000 ⫻ g for 5 min at 4°C and were reacted with
luciferase substrate (Promega, Madison, WI). The intensity of luciferase
activity was measured by a TD-20/20 luminometer (Turner Designs,
Sunnyvale, CA) with a 5-s delay and 10-s read.
Analysis of membrane-associated proteins. Biotinylation of cell surface proteins was used to identify membrane-associated proteins of Vero
cells infected with each of the designated viruses. Briefly, surface proteins
of Vero cells infected with the designated viruses at an MOI of 3 were
biotinylated at 12 hpi and isolated with a Pierce cell surface protein isolation kit (Thermo Scientific, Waltham, MA). The isolated proteins, whole
lysates, and flowthrough were analyzed by Western blots with specific
antibodies to gB, gC, gD, gH, gM, UL11, and VP5.
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gM or UL11 gene expression, complementation assays in which
Vero cells were transfected with plasmids expressing either gM or
UL11 and subsequently infected with the mutant viruses were
performed. These experiments revealed that more than 50% of
viral plaques (data not shown) were rescued to either a gB⌬28 or
gKsyn20 plaque morphology (Fig. 2B). To quantify the fusogenic
capacity of mutant viruses, we utilized a luciferase-based assay to
measure cell-to-cell fusion (see Materials and Methods). The
gKsyn20 mutation caused much higher virus-induced cell fusion
than the gB⌬28 mutation, most likely because this virus spread
more rapidly than the gB⌬28 virus. Moreover, the amount of
gKsyn20-caused cell fusion was much higher than that obtained
by transfection of both luciferase gene and T7 polymerase in the
same cell population (positive control). Deletion of either gM or
UL11 completely abrogated gKsyn20-mediated cell fusion (Fig.
3A). Similarly, deletion of either gM or UL11 severely inhibited
gB⌬28-induced cell fusion, exhibiting cell fusion levels lower than
those produced by the wild-type virus (Fig. 3B). To assess the
relative effect of each mutation alone or in combination on virus
replication, viral titers were obtained at 24 or 48 h after infection
of Vero cells at an MOI of either 0.2 or 3.0. All viruses appeared to
replicate with efficiencies approximately equal to that of the parental wild-type virus irrespective of the presence of the engineered mutations (Fig. 4).
Effect of mutations on the synthesis and cell surface expression of viral glycoproteins. The effects of a lack of either gM or
UL11 expression on the synthesis of the viral glycoproteins gB, gC,
gD, and gM and the membrane-associated protein UL11 were
assessed using Western immunoblots of whole-cell lysates. A lack
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of either gM or UL11 expression was confirmed via the inability of
anti-gM or anti-UL11 antibody to detect the presence of either
protein in their respective mutant viruses. Overall, neither lack of
gM expression nor lack of UL11 expression drastically affected the
synthesis of gB, gC, and gD. Furthermore, lack of gM did not affect
the synthesis of UL11 and lack of UL11 did not affect gM levels
(Fig. 5).
Surface glycoprotein expression profiles of Vero cells infected
with the designated viruses were analyzed by cell surface biotinylation experiments (Fig. 6). Viral glycoproteins expressed on infected cell surfaces were biotinylated under live conditions. Biotinylated proteins were subsequently isolated by streptavidin
immunoprecipitation and analyzed by Western immunoblots
(see Materials and Methods). The HSV-1 capsid protein VP5 was
included in the immunoblots as a negative control since it is not
expected to be expressed in infected cellular plasma membranes.
Lack of either gM or UL11 did not affect overall expression of the
viral glycoproteins gB, gC, gD, and gH on HSV-1(F)-infected cell
surfaces (Fig. 6A). Similar results were obtained for the gB⌬28
virus (Fig. 6B) except in the case of gKsyn20-infected cells, most
likely due to rapid loss of fused cells (syncytia) (Fig. 6C).
UL20 protein physically interacts with gM in virus-infected
cells. To determine whether gM and UL11 interact directly with
gB or the gK/UL20 complex, we performed two-way immunoprecipitation experiments. The results revealed that gM interacted
with UL20 but not gB, since gM immunoprecipitates contained
UL20 (Fig. 7, lane 2) but not gB (Fig. 7, lane 8) and UL20 immunoprecipitates contained gM (Fig. 7, lane 4). Immunoprecipitations with gB, gD, or gH failed to reveal any interactions with gM
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FIG 2 Plaque morphology of mutant viruses in comparison to HSV-1(F)-YE102. Confluent monolayers of Vero cells were infected with wild-type and mutant
viruses at an MOI of 0.0001 and immunohistochemically stained at 48 hpi using polyclonal anti-HSV rabbit sera as described in Materials and Methods. (A)
Representative viral plaques of HSV-1(F)-YE102 wild-type virus and the syncytial mutant viruses gB⌬28 and gKsyn20 on Vero cells. (B) Representative viral
plaques of syncytial mutant viruses lacking gM or UL11 in the absence or presence of transient complementation with either gM- or UL11-expressing plasmid.
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Gene
nameb

nt
position

UL1
UL6
UL8

9,604
15,564
18,753
19,678

UL13

26,904

NC

34,226
35,711

UL19
UL21
NC
UL24

40,404
43,555
47,555
47,695
47,910
47,911

UL27
UL34

53,638
69,681

UL37

81,439
82,015
82,806
82,815

UL38
UL39

84,529
87,759

aa
difference

aa
position

gL
Capsid portal protein
Helicase-primase subunit
Helicase-primase subunit
C¡Y

507

Tegument serine/threonine
protein kinase

A¡T

15

Major capsid protein
Tegument protein

A¡V
A¡V

86

S¡N

45

C¡R
A¡V

45
424

88,762

UL48

Gene description

103,969
104,340

T¡A

212

UL50
UL55
UL56
NC

107,306
115,491
116,406
132,421
134,690
137,938

P¡T
M¡I
A¡T

134
35
137

US7

139,976

Nuclear protein
Nuclear protein
Nuclear protein
gB
Nuclear egress membrane
protein
Tegument protein
Tegument protein
Tegument protein
Tegument protein
Capsid triplex subunit 1
Ribonucleotide reductase
subunit 1
Ribonucleotide reductase
subunit 1

DISCUSSION

Herpes viral proteins and glycoproteins have been shown to extensively interact within the virion particle and in infected cells.
Interactions among the viral glycoproteins gB, gD, gH, gL, and gK
and the membrane protein UL20 are known to be involved in
regulation of membrane fusion phenomena occurring during virus entry and virus-induced cell fusion. The purpose of this investigation was to assess whether the glycoprotein gM and the membrane-associated protein UL11, both of which are highly
conserved in all herpesviruses, are involved in these membrane
fusion phenomena. Herein, we show that the absence of either gM
or UL11 expression abrogated virus-induced cell fusion caused by
strong syncytial mutations in either gB or gK and that gM interacted with the gK/UL20 protein complex. Moreover, virions produced in the absence of gM or UL11 entered more slowly into cells
than did their parental wild-type virus. These results suggest that
both gM and UL11 directly or indirectly interact and regulate the
HSV-1 membrane fusion machinery during virus-induced cell fusion and virus entry.
Glycoprotein gM is a highly hydrophobic glycoprotein predicted to span membranes eight times. It is highly conserved in all
alphaherpesviruses, suggesting that it plays an essential role in
herpes infections. Previous work indicated that insertional inactivation of the gM gene inhibited cell fusion caused by a syncytial
mutation in gB (gBsyn; Ala to Val at gB amino acid 855) (36, 37).
This particular syncytial mutation causes significantly smaller
amounts of virus-induced cell fusion than the gB⌬28 mutation,
with the latter being the strongest gB syncytial mutation causing
extensive cell fusion of most cell types in tissue culture (54, 55).
Similarly, the gKsyn20 mutation (Ala to Val at gK amino acid 40)
causes extensive virus-induced cell fusion in most cell types (30).

Transactivating tegument
protein VP16
Transactivating tegument
protein VP16
Deoxyuridine triphosphatase
Nuclear protein UL55
Membrane protein UL56

gI

a

nt, nucleotide; aa, amino acid.
b
NC, noncoding region.

(not shown). Similar immunoprecipitations with UL11 failed to
reveal any interactions with gB, gC, gD, gH, gM, gK, or UL20 (data
not shown).
HSV-1 gM and UL11 are required for wild-type-like virus
entry. Virus-induced cell fusion and fusion of the viral envelope
with cellular membranes during virus entry are thought to occur
via similar mechanisms involving viral glycoproteins. Therefore,
we tested whether a lack of either gM or UL11 affected the kinetics
of virus entry into Vero cells. A lack of either gM or UL11 caused
slower entry of both viruses into Vero cells compared to the wildtype virus (Fig. 8). Similarly, lack of either gM or UL11 caused
slower virus entry in the presence of either the gB⌬28 or gKsyn20
mutation (data not shown).
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FIG 3 Fusion activity of wild-type and mutant viruses. Fusion activity of
each virus was quantified by a luciferase-based assay (see Materials and
Methods). The extent of fusion was assessed at 12 and 24 hpi for the wildtype virus and all mutant viruses containing the gKsyn20 mutation (A) or
the gB⌬28 mutation (B).
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TABLE 1 Summary of differences between the published HSV-1(F) and
the HSV-1(F) from pYE102baca

Kim et al.

Our results show that a lack of gM abrogated virus-induced cell
fusion caused by either a gKsyn20 or gB⌬28 mutation, in agreement with previous findings (36, 37). Glycoprotein gM has been
suggested to function in either retaining viral glycoproteins to
TGN membranes or retrieving them from plasma membranes to
TGN (32). In contrast to these published findings, deletion of gM
did not appear to appreciably impact the overall level of other viral
glycoproteins or their relative levels expressed on cell surfaces.
Transient expression of HSV-1, PRV, and KSHV gM appeared to
inhibit cell fusion caused by simultaneous expression of gB, gD,
gH, and gL, suggesting potential interactions between gM and one
or more of these viral glycoproteins (34, 35). However, extensive
two-way coimmunoprecipitation experiments failed to indicate
interactions between gM and either gB or gD, suggesting that gM
may indirectly interact with these proteins to regulate cell fusion.
Additional protein-protein interaction experiments revealed that
gM interacts with the UL20 protein, the interacting partner of gK.
We have shown that the gK/UL20 protein complex interacts with
gB (31); therefore, it is likely that a lack of gM affects the ability of
the gK/UL20 complex to bind and regulate the fusogenic properties of gB. In this regard, gM is a new member of the HSV-1 fusion
machinery composed of gB, gH, gD, gL, gK, UL20, and now gM.
Recently, it was shown that VP22 forms a protein complex with
gM and gE that may affect the functions of these proteins (56);
thus, gE may also participate in this glycoprotein network on infected cell surfaces and virion envelopes.
The UL11 protein was of particular interest to these investigations due to its high conservation among all herpesviruses and its

FIG 5 Characterization of glycoprotein expression by wild-type and mutant
viruses. The overall synthesis of each viral protein was assessed by Western
immunoblotting. Each lane represents infected cellular extracts from cells infected with either wild-type or mutant virus: 1, wild type; 2, gB⌬28; 3, gB⌬28/
⌬gM; 4, gB⌬28/⌬UL11; 5, mock infection; 6, gKsyn20; 7, gKsyn20/⌬gM; 8,
gKsyn20/⌬UL11. gB, gC, gD, gM, and UL11 denote antibodies specific for each
protein.
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ability to interact with the carboxyl terminus of glycoprotein gE
and multiple tegument proteins (42). We show that UL11 is expressed on infected cell surfaces at very low levels, if at all, in
agreement with the prediction that UL11 is attached to cytoplasmic sides of plasma membranes via its myristoylated and palmitoylated residues and its interaction with the cytoplasmic tail of gE
(32, 38–42). Surprisingly, a lack of UL11 severely inhibited both
gB⌬28- and gKsyn20-caused virus-induced cell fusion. The
gB⌬28 results confirm recent findings that UL11 is required for
gBsyn (A855V) but significantly extend these findings, since deletion of the gB carboxyl terminus causes extensive cell fusion in all
cell types, unlike the gBsyn (A855V) mutation (55). Moreover, a
lack of UL11 inhibited fusion caused by the gKsyn20 mutation,
which is a dominant syncytial mutation causing fusion of all cell
types tested.
A lack of gE (36, 37) and UL11 (43) was reported to prevent
gBsyn-mediated virus-induced cell fusion. Immunofluorescence
and flow cytometry experiments failed to detect substantially
smaller amounts of gE in cells infected with either gM-null or
UL11-null virus (data not shown). This suggests that the observed
inhibition of virus-induced cell fusion in the absence of UL11 is
not due to a lack of gE cell surface expression. In contrast to our
findings, it was recently shown that deletion of UL11 appeared to
reduce gE cell surface expression in Vero but not HaCaT cells by
fluorescence microscopy (43). It is possible that different results
are obtained due to the use of HSV-1 (KOS) (43) versus HSV-1(F)
(this study). Additional studies will be needed to resolve whether a
lack of UL11 substantially affects gE expression and function on
infected cell surfaces.
Virus-induced cell fusion and fusion of the viral envelope with
cellular membranes during virus entry are thought to occur via
similar mechanisms involving viral glycoprotein gB and cellular
receptors (15). We have shown that gK and UL20 are expressed in
virion envelopes and are involved in virus entry, since deletion of
gK or a small segment of gK that interacts with gB causes virions to
enter more slowly than their parental wild-type virus into cells and
alter their ability to utilize HSV-1-specific receptors (29, 52, 57).
Similarly, virions produced in the absence of either gM or UL11
exhibited slower kinetics of entry into Vero cells than did their
parental virus. gM is known to be expressed in virion envelopes
(48). Also, UL11 is a structural component of virions (58) and
interacts with gE and other tegument proteins in infected cells
(43). Recently, it was shown that VP22 bridges a complex between
gE and gM (56). Therefore, it is conceivable that UL11 binding to
gE can indirectly affect both gE and gM functions, causing both
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FIG 4 Replication kinetics of the wild-type and mutant viruses. Confluent Vero cell monolayers were infected with each virus in triplicate at either a low MOI
(0.2) (A) or a high MOI (3.0) (B), and viral titers were obtained by plaque assay on Vero cells at 24 and 48 hpi. Error bars represent standard deviations.
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FIG 7 UL20 protein interacts with gM in virus-infected cells. Vero cell mono-

envelopes, causing the observed inhibition in virus entry. Additional investigations beyond the scope of this work are needed to
address this issue in the future.
Collectively, these results suggest that both gM and UL11 are
required for virus-induced cell fusion and efficient virus entry,
most likely because they directly or indirectly interact with the
viral fusion machinery. Glycoprotein gM directly interacts with
the gK/UL20 protein complex. We did not detect any UL11 interactions with either gB, gC, gD, gH, gM, or gK/UL20. It is possible
that such interactions are weak or of transient nature that cannot
be detected via coimmunoprecipitation experiments. UL11 interacts with gE and VP22 interacts with both gE and gM (56), suggesting that gE also participates in indirect interactions with the
fusion machinery. Additional experiments are needed to ascertain
the intracellular localization of UL11 and its potential functions in
virus-induced cell fusion. Overall, it is apparent that multiple pro-

FIG 6 Cell surface expression of viral glycoproteins on infected cell surfaces by
wild-type and mutant viruses. At 12 hpi, whole lysates were prepared and membrane-associated proteins were isolated (see Materials and Methods). Flowthrough-labeled lanes represent cytoplasmic proteins. Each lane represents wildtype or mutant virus-infected cell extracts. (A) Lane 1, wild type; lane 2, ⌬gM; lane
3, ⌬UL11. (B) Lane 1, gB⌬28; lane 2, gB⌬28/⌬gM; lane 3, gB⌬28/⌬UL11. (C) Lane
1, gKsyn20; lane 2, gKsyn20/⌬gM; lane 3, gKsyn20/⌬UL11. gB, gC, gD, gH, gM,
UL11, and VP5 denote antibodies specific for each protein.

the observed inhibition of virus-induced cell fusion and the slower
kinetics of the UL11-null virus in comparison to its parental wildtype virus. Alternatively, it is possible that absence of gM or UL11
affects the incorporation of other viral glycoproteins into virion
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FIG 8 Entry kinetics of HSV-1(F) (WT), ⌬gM, and ⌬UL11 viruses into Vero
cells. Vero cell monolayers were infected with either HSV-1(F), ⌬gM, or
⌬UL11 virus at 250 PFU per tissue culture well. The kinetics of virus entry at
34°C was measured (see Materials and Methods). Mean values and standard
deviations of three independent experiments are shown. The relative efficiency
of entry was calculated by obtaining the linear regression slope during the
exponential viral growth period (0 to 120 min). The mean value and the standard deviation of each slope are shown.
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layers were infected with HSV-1(F) or HSV-1(F)-YE102-VC1 (having UL20
protein tagged with the 3⫻FLAG epitope and gK tagged with the V5 epitope).
Cellular extracts were prepared at 24 hpi, and the presence of gB, gM, or UL20
was detected using Western immunoblots after immunoprecipitation (IP)
with designated antibodies. Lanes 1, 3, 5, and 7, antigen from HSV-1(F)infected cells; lanes 2, 4, 6, and 8, antigen from HSV-1(F)-YE102-VC1-infected
cells; lane M demarcates positions of molecular mass markers (10 to 250 kDa;
Bio-Rad). Anti-gB (␣-gB), anti-gM (␣-gM), and anti-FLAG (␣-UL20) denote
probed antibodies, and gB-IP, gM-IP, and UL20-IP (FLAG-IP) represent antibodies used for immunoprecipitation. gB, H, L, gM, and UL20 denote gB,
heavy chain, light chain, gM, and UL20 proteins, respectively.

tein-protein interactions occur among viral glycoproteins and
tegument proteins that regulate membrane fusion phenomena in
HSV-1 infections.
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